Internal Medicine, Gastroenterology · Marietta, GA
NPI
1831118405
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
488 Kennesaw Ave NW, Suite 200
Marietta, GA, 30060
Phone (770) 427-3075
Groups this clinician bills Medicare through
Medicare paid, 2024
$145K
4,959 services
Medicare patients, 2024
395
Average age 72
Drug cost, 2024
$670K
1,370 prescriptions
Company payments, 2025
$4,378
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna V Longacre was code 99214 (office e&m - established), 163 times for 128 patients. In total Anna V Longacre billed 4,959 services in 37 codes, and Medicare paid $145K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 163 | 128 | $93.35 | $15K |
| 43239 Upper GI Endoscopy | Facility | 83 | 80 | $88.05 | $7,308 |
| 45380 Lower GI Endoscopy - Other | Facility | 74 | 74 | $130.74 | $9,675 |
| 99213 Office E&M - Established | Office | 54 | 49 | $66.51 | $3,591 |
| 99203 Office E&M - New | Office | 52 | 52 | $84.41 | $4,389 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 41 | 41 | $176.72 | $7,246 |
| 45385 Colonoscopy - Lesion Removal | Facility | 37 | 37 | $207.68 | $7,684 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 26 | 26 | $166.98 | $4,342 |
| 43450 Digestive/Gastrointestinal | Facility | 21 | 21 | $31.08 | $653 |
| 99215 Office E&M - Established | Office | 20 | 18 | $125.25 | $2,505 |
| 99233 Hospital E&M - Subsequent | Facility | 18 | 13 | $91.89 | $1,654 |
| 99204 Office E&M - New | Office | 14 | 14 | $116.18 | $1,627 |
| 99222 Hospital E&M - Initial | Facility | 12 | 12 | $101.66 | $1,220 |
| 99442 Telephone Services | Office | 11 | 11 | $52.06 | $573 |
By year: 2022 $242K for 9,273 services; 2023 $175K for 6,013 services; 2024 $145K for 4,959 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anna V Longacre prescribed most often to Medicare patients was Omeprazole, with 283 prescriptions and refills. In total Anna V Longacre wrote 1,370 Medicare prescriptions that cost $670K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 283 | 641 | 102 | $2,521 |
| Colesevelam Hcl Generic | 121 | 200 | 48 | $8,604 |
| Famotidine Generic | 119 | 285 | 44 | $1,144 |
| Pantoprazole Sodium Generic | 113 | 279 | 44 | $1,507 |
| Linzess Linaclotide | 92 | 162 | 31 | $86K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 83 | 83 | 82 | $5,931 |
| Ondansetron Odt Ondansetron | 54 | 74 | 39 | $1,372 |
| Creon Lipase/Protease/Amylase | 41 | 57 | 14 | $130K |
| Dexlansoprazole Dr Dexlansoprazole | 39 | 64 | 11 | $10K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 33 | 33 | 33 | $575 |
| Mesalamine Generic | 25 | 53 | Under 11 | $14K |
| Sucralfate Generic | 24 | 50 | 13 | $888 |
| Lubiprostone Generic | 23 | 25 | Under 11 | $1,708 |
| Promethazine Hcl Generic | 20 | 28 | Under 11 | $160 |
| Mesalamine Er Mesalamine | 18 | 40 | Under 11 | $5,858 |
Brand drugs: 349 claims; generic drugs: 1,007 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna V Longacre $4,378 ($4,378 in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $734.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 40 | $734 |
| Janssen Biotech, Inc. JNJ | 12 | $580 |
| Lilly USA, LLC LLY | 12 | $334 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 18 | $292 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 10 | $284 |
| Genzyme Corporation SNY | 11 | $272 |
| Ardelyx, Inc. ARDX | 8 | $236 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $228 |
| Aimmune Therapeutics, Inc. | 7 | $217 |
| Madrigal Pharmaceuticals MDGL | 4 | $178 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.